Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS).

The Journal of the Association of Physicians of India

Volumn 61, Issue 2, 2013, Pages 97-101

  Kaul, Upendra ^a   Varma, Jagmohan ^a   Kahali, Dhiman ^a   Hiremath, M S ^a   Dani, Sameer ^a   Dalal, Jamshed ^a   Ramchandran, P ^a   Rane, Rajendra ^a   Barkate, Hanmant ^a   Jindal, Chhavi ^a  

^a Intas Pharmaceuticals Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INDIA; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HEPTANOIC ACIDS; HUMANS; INDIA; MALE; MIDDLE AGED; PYRROLES; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84897018786     PISSN: 00045772     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)